Illumina buys Jeff Bezos-backed cancer-testing firm Grail in deal worth $8 billion.
Illumina will get access to Grail's "liquid biopsy" blood test, Galleri, which helps identify early-stage cancers and is expected to be launched commercially in 2021, betting on a market that is expected to grow rapidly in coming years.
Grail was founded by Illumina as a separate company in 2016 and had raised about $2 billion, with investors including Bezos andIllumina is Grail's largest shareholder, holding a 14.5% stake. Grail stockholders, including Illumina, will receive $3.5 billion in cash and $4.5 billion in shares of Illumina stock,Grail plans to follow Galleri with more blood tests for cancer diagnosis, detection and post-treatment monitoring of cancer patients.
Most liquid biopsies use next-generation sequencing to scan blood samples for fragments of tumor DNA in people previously diagnosed with cancer. Analysts peg the market for liquid biopsies in the range of least $30 billion to $130 billion in the United States alone."We don't see the clear fit for acquiring a company that is still at a stage where clinical studies and clinical product development are still critical and will be for years," Cowen analyst Doug Schenkel said in a client note.
Acquiring Grail would also create conflicts with many of Illumina's existing clinical customers, Schenkel added, noting that many of Illumina's major customers have ambitions to develop liquid biopsy-based cancer screening tools.Reuters contributed to this report.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion dealIllumina Inc said on Monday it would buy cancer screening startup Grail Inc in a cash-and-stock deal worth $8 billion, buying out investors including Jeff Bezos and snatching back a business it hived off four years ago as a separate company.
Weiterlesen »
Illumina to pay $8 billion for Jeff Bezos-backed cancer testing firm GrailGene sequencing company Illumina Inc will pay $8 billion in cash and stock to buy cancer screening startup Grail Inc, the companies said on Monday.
Weiterlesen »
Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion dealIllumina Inc said on Monday it would buy cancer screening startup Grail Inc in a cash-and-stock deal worth $8 billion, buying out investors including Jeff Bezos and snatching back a business it hived off four years ago as a separate company.
Weiterlesen »
Illumina to pay $8 billion for Jeff Bezos-backed cancer testing firm GrailGene sequencing company Illumina Inc will pay $8 billion in cash and stock to buy cancer screening startup Grail Inc, the companies said on Monday.
Weiterlesen »
French telecoms group Iliad plans to buy Poland's Play in $4.15 billion dealIliad plans to acquire Polish mobile phone operator Play in a 3.5 billion euros ($4.15 billion) deal, the French telecoms group said on Monday, adding that it has secured a deal to buy 40% of the firm's capital from key shareholders.
Weiterlesen »
The West Coast's wildfire real estate crisis has $8 billion at stake - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »